Glaucocalyxin B Alleviates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting TLR/NF-κB and Activating Nrf2/HO-1 Pathway.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 44, n. 6, p. 2091, doi. 10.1159/000485947
- By:
- Publication type:
- Article